258 related articles for article (PubMed ID: 16503077)
1. Staging systems for hepatocellular carcinoma: should we all use the BCLC system?
Marrero JA
J Hepatol; 2006 Apr; 44(4):630-2. PubMed ID: 16503077
[No Abstract] [Full Text] [Related]
2. Prospective validation of the Barcelona Clinic Liver Cancer staging system.
Cillo U; Vitale A; Grigoletto F; Farinati F; Brolese A; Zanus G; Neri D; Boccagni P; Srsen N; D'Amico F; Ciarleglio FA; Bridda A; D'Amico DF
J Hepatol; 2006 Apr; 44(4):723-31. PubMed ID: 16488051
[TBL] [Abstract][Full Text] [Related]
3. BCLC stage B is a better designation for single large hepatocellular carcinoma than BCLC stage A.
Jung YK; Jung CH; Seo YS; Kim JH; Kim TH; Yoo YJ; Kang SH; Yim SY; Suh SJ; An H; Yim HJ; Yeon JE; Byun KS; Um SH
J Gastroenterol Hepatol; 2016 Feb; 31(2):467-74. PubMed ID: 26332049
[TBL] [Abstract][Full Text] [Related]
4. Analysis of BCLC treatment indications. Have BCLC modified our choice of treatment in HCC patients? A retrospective study.
Maria S; Gaetano LG; Rosanna PT; Rosario L; Elisa M; Antonietta TM; Domenico R; Stefano P
Hepatogastroenterology; 2009; 56(93):1090-4. PubMed ID: 19760948
[TBL] [Abstract][Full Text] [Related]
5. Comparison of three current staging systems for hepatocellular carcinoma: Japan integrated staging score, new Barcelona Clinic Liver Cancer staging classification, and Tokyo score.
Chung H; Kudo M; Takahashi S; Hagiwara S; Sakaguchi Y; Inoue T; Minami Y; Ueshima K; Fukunaga T; Matsunaga T
J Gastroenterol Hepatol; 2008 Mar; 23(3):445-52. PubMed ID: 17683486
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the usefulness of three staging systems for hepatocellular carcinoma (CLIP, BCLC, and JIS) in Japan.
Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J
Am J Gastroenterol; 2005 Aug; 100(8):1764-71. PubMed ID: 16086713
[TBL] [Abstract][Full Text] [Related]
7. Is the search for a single comprehensive staging system for hepatocellular carcinoma an elusive one?
McClune AC; Tong MJ
J Clin Gastroenterol; 2009 Sep; 43(8):697-8. PubMed ID: 19636257
[No Abstract] [Full Text] [Related]
8. Controversies in staging of hepatocellular carcinoma.
Burns JM; Greene FL
J Hepatobiliary Pancreat Surg; 2005; 12(6):456-62. PubMed ID: 16365818
[TBL] [Abstract][Full Text] [Related]
9. Predicting survival in early hepatocellular carcinoma.
Ryder S
Gut; 2005 Mar; 54(3):328-9. PubMed ID: 15710977
[No Abstract] [Full Text] [Related]
10. Staging classifications for hepatocellular carcinoma.
Van Deusen MA; Abdalla EK; Vauthey JN; Roh MS
Expert Rev Mol Diagn; 2005 May; 5(3):377-83. PubMed ID: 15934814
[TBL] [Abstract][Full Text] [Related]
11. A modified TNM-based Japan Integrated Score combined with AFP level may serve as a better staging system for early-stage predominant hepatocellular carcinoma patients.
Yen YH; Changchien CS; Wang JH; Kee KM; Hung CH; Hu TH; Lee CM; Lin CY; Wang CC; Chen TY; Huang YJ; Lu SN
Dig Liver Dis; 2009 Jun; 41(6):431-41. PubMed ID: 19185555
[TBL] [Abstract][Full Text] [Related]
12. Prognostic prediction in patients with hepatocellular carcinoma.
Sala M; Forner A; Varela M; Bruix J
Semin Liver Dis; 2005; 25(2):171-80. PubMed ID: 15918146
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment.
Vauthey JN; Ribero D; Abdalla EK; Jonas S; Bharat A; Schumacher G; Lerut J; Chapman WC; Hemming AW; Neuhaus P
J Am Coll Surg; 2007 May; 204(5):1016-27; discussion 1027-8. PubMed ID: 17481532
[TBL] [Abstract][Full Text] [Related]
14. Comparison of clinical staging systems in predicting survival of hepatocellular carcinoma patients receiving major or minor hepatectomy.
Chen TW; Chu CM; Yu JC; Chen CJ; Chan DC; Liu YC; Hsieh CB
Eur J Surg Oncol; 2007 May; 33(4):480-7. PubMed ID: 17129701
[TBL] [Abstract][Full Text] [Related]
15. The prognosis and survival analysis according to seven staging systems of hepatocellular carcinoma following curative resection.
Choi SB; Lee JG; Kim KS; Yoon DS; Choi JS; Lee WJ; Kim BR
Hepatogastroenterology; 2008; 55(88):2140-5. PubMed ID: 19260493
[TBL] [Abstract][Full Text] [Related]
16. The challenge of prognosis and staging for hepatocellular carcinoma.
Marrero JA; Kudo M; Bronowicki JP
Oncologist; 2010; 15 Suppl 4():23-33. PubMed ID: 21115578
[TBL] [Abstract][Full Text] [Related]
17. Comparison of seven staging systems in cirrhotic patients with hepatocellular carcinoma in a cohort of patients who underwent radiofrequency ablation with complete response.
Guglielmi A; Ruzzenente A; Pachera S; Valdegamberi A; Sandri M; D'Onofrio M; Iacono C
Am J Gastroenterol; 2008 Mar; 103(3):597-604. PubMed ID: 17970836
[TBL] [Abstract][Full Text] [Related]
18. Staging systems of hepatocellular carcinoma: A review.
Tellapuri S; Sutphin PD; Beg MS; Singal AG; Kalva SP
Indian J Gastroenterol; 2018 Nov; 37(6):481-491. PubMed ID: 30593649
[TBL] [Abstract][Full Text] [Related]
19. Staging for hepatocellular carcinoma: look for a perfect classification system.
Huo TI; Lee SD; Wu JC
J Hepatol; 2004 Jun; 40(6):1041-2; author reply 1042-3. PubMed ID: 15158351
[No Abstract] [Full Text] [Related]
20. Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization.
Kim JH; Kim JH; Choi JH; Kim CH; Jung YK; Yim HJ; Yeon JE; Park JJ; Kim JS; Bak YT; Byun KS
Scand J Gastroenterol; 2009; 44(3):346-57. PubMed ID: 18991165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
